Literature DB >> 12998619

[Effect of thrombin and heparin on fibrinolysis].

E EICHENBERGER.   

Abstract

Entities:  

Keywords:  FIBRINOLYSIN; HEPARIN/effects; THROMBIN/effects

Mesh:

Substances:

Year:  1952        PMID: 12998619     DOI: 10.1007/BF02174416

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  6 in total

1.  Fibrinolytic activity of purified thrombin.

Authors:  M M GUEST; A G WARE
Journal:  Science       Date:  1950-07-07       Impact factor: 47.728

2.  [Investigations of the fibrinolytic effect of heparin].

Authors:  H VINAZZER
Journal:  Wien Z Inn Med       Date:  1951-04

3.  [Colorimetric determination of fibrinolysis using the tyrosine equivalent].

Authors:  E KAUTZSCH; A RAUSCHER
Journal:  Klin Wochenschr       Date:  1950-10-15

4.  [Mechanism of thrombin formation in the isolated system].

Authors:  H E SCHULTZE; G SCHWICK
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1951

5.  [Salts in blood and fibrinolysis in human serum].

Authors:  R MARX; C HILLER
Journal:  Klin Wochenschr       Date:  1952-01-15

6.  [Fermentative effectors in fibrinolyses].

Authors:  H BAYERLE; G KIRSTEIN
Journal:  Klin Wochenschr       Date:  1952-04-15
  6 in total
  4 in total

1.  [Studies on fibrinolysis of experimental coagulation thrombi by thrombo-stop].

Authors:  W SANDRITTER; H HERMANN
Journal:  Klin Wochenschr       Date:  1955-09-01

2.  [Determination of the profibrinolysin time].

Authors:  S WITTE; P DIRNBERGER
Journal:  Klin Wochenschr       Date:  1954-02-01

3.  Effects of heparin and epsilon-aminocaproic acid in dogs on plasmin-125-I generation in response to urokinase injections and venous injury.

Authors:  Y Takeda; T R Parkhill; M Nakabayashi
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

4.  Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by haparin.

Authors:  P W Straub; G Riedler; P G Frick
Journal:  J Clin Pathol       Date:  1967-03       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.